HEALTH
Health Articles
PharmAla Biotech $MDMA Investor Ecstasy Just Beginning
PharmAla is the first for-profit company to synthesize clinical-grade (GMP) MDMA and make it available for sale to both researchers and qualified patients. PharmAla will increasingly develop a target on its back for acquisition and we expect a rise in marketcap via...
Long Position: Editas Medicine (EDIT) Genome Editing Company Looks Good Here, Primed for Acquisition
Editas Medicine currently trades at an enterprise value of just $561 million, but its IP portfolio alone is worth billions. This stock traded at over $80/share 2 years ago and is now under $9/share, however the reasons for buying then are just as strong now. It’s...
Long Position: Vicarious Surgical Inc. (RBOT) Revolutionizing the Future of Surgical Medicine
Vicarious Surgical Robotic System was added to Time Magazine’s list for the 'Best Inventions of 2022' -- for reference; Apple’s iPhone was featured by Time in 2007 Best Inventions -- NYSE: RBOT has moon-shot potential. Vicarious Surgical Inc. (RBOT)...
Age-related memory loss can be reversed, scientists make breakthrough in mice
Age-related memory loss can be reversed, scientists make breakthrough in miceby Alfred NewmanBottom Line/Synopsis: “Scientists at Cambridge & Leeds have successfully reversed age-related memory loss in mice and say their discovery could lead to the development of...
